Cellerant commences CLT-008 Phase I/II trial in patients with leukemia
Links shared publicly online about this topic.
- 419total visits
Cellerant commences CLT-008 Phase I/II trial in patients with leukemia
Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced the initiation of a Phase I/II clinical trial of CLT-008 in patients receiving intensive post-remission chemotherapy for high-risk leukemia or myelodysplasia.
View full resource at news-medical.net
Tags: Cancer, Leukemia, Disease and Condition, Clinical Trial, Biotech, Oncology, News
Most Recently Shared on March 23, 2011 at 7:55 am By:
Oncology News: Cellerant commences CLT-008 Phase I/II trial in patients with leukemia: Cellerant Therapeutics In... http://bit.ly/gyjGpq
Also Shared By:
Advertisement
News-Medical.Net
@NewsMedical
Cellerant commences CLT-008 Phase I/II trial in patients with leukemia: Cellerant Therapeutics Inc., a biotechno... http://bit.ly/gyjGpq
1 year ago...